Accéder au contenu
MilliporeSigma
Toutes les photos(1)

Documents

T-077

Supelco

3,3′,5-Triiodo-L-thyronine-13C6 solution

100 μg/mL in methanol with 0.1N NH3, ampule of 1 mL, certified reference material, Cerilliant®

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme


About This Item

Formule empirique (notation de Hill):
13C6C9H12I3NO4
Numéro CAS:
Poids moléculaire :
656.93
Code UNSPSC :
41116107
Nomenclature NACRES :
NA.24

Qualité

certified reference material

Forme

liquid

Caractéristiques

(Snap-N-Spike®)

Conditionnement

ampule of 1 mL

Fabricant/nom de marque

Cerilliant®

Concentration

100 μg/mL in methanol with 0.1N NH3

Technique(s)

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

Application(s)

clinical testing

Format

single component solution

Température de stockage

−20°C

Chaîne SMILES 

IC1=CC(O[13C]2=[13C](I)[13CH]=[13C](C[C@H](N)C(O)=O)[13CH]=[13C]2I)=CC=C1O

InChI

1S/C15H12I3NO4/c16-9-6-8(1-2-13(9)20)23-14-10(17)3-7(4-11(14)18)5-12(19)15(21)22/h1-4,6,12,20H,5,19H2,(H,21,22)/t12-/m0/s1/i3+1,4+1,7+1,10+1,11+1,14+1

Clé InChI

AUYYCJSJGJYCDS-HRUXDFQWSA-N

Description générale

A Certified Spiking Solution® of the internal standard 3,3´,5-Triiodo-L-thyronine-13C6 (T3-13C6). 3,3′,5-Triiodo-L-thyronine or T3 is a thyroid hormone involved with many physiological processes in the human body including growth and development, metabolism, body temperature and heart rate. This internal standard is suitable for quantitation of free and total T3 serum levels by LC-MS/MS for determination of hyperthyroidism caused by excess T3.

Informations légales

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
CERTIFIED SPIKING SOLUTION is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

Pictogrammes

FlameSkull and crossbonesHealth hazard

Mention d'avertissement

Danger

Classification des risques

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

Organes cibles

Eyes,Central nervous system

Code de la classe de stockage

3 - Flammable liquids

Classe de danger pour l'eau (WGK)

WGK 2

Point d'éclair (°F)

49.5 °F

Point d'éclair (°C)

9.7 °C


Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Mitchell S Cappell et al.
Digestive diseases and sciences, 59(10), 2381-2389 (2014-05-20)
To quantitatively describe the syndrome of Mallory-Weiss tears associated (MWa) with antecedent transesophageal echocardiography (TEE) as a distinct syndrome. Cases of MWa were identified by comprehensive, computerized literature search via PubMed and review of textbooks and monographs on TEE and
Ali Tabatabaei et al.
Journal of cataract and refractive surgery, 40(7), 1092-1096 (2014-05-20)
To compare the accuracy of 3 imaging modalities for preoperative evaluation of the posterior lens capsule in traumatic cataract. Farabi Eye Hospital, Tehran, Iran. Case series. The study comprised eyes with traumatic cataract opaque enough to prevent visualization of the
K Maruyama et al.
British journal of anaesthesia, 113(3), 491-500 (2014-05-20)
We wanted to demonstrate the feasibility of a novel computer-assisted ventilator alarm system, the support system for care of mechanically ventilated patients (SCMVP), to detect gas leaks and provide graphical information on the site of the leak in a manikin
S W Grant et al.
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 48(1), 38-44 (2014-05-20)
A number of contemporary risk prediction models for mortality following elective abdominal aortic aneurysm (AAA) repair have been developed. Before a model is used either in clinical practice or to risk-adjust surgical outcome data it is important that its performance
Christina Stefanaki et al.
The Journal of dermatological treatment, 26(2), 139-142 (2014-05-20)
All available treatments for anogenital warts have substantial failure rates. An immunomodulating treatment that enhances the patient's own immunity could be valuable as an adjuvant to conventional methods. About 123 patients were enrolled in this study and were randomized either

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique